GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InventisBio Co Ltd (SHSE:688382) » Definitions » Price-to-Owner-Earnings

InventisBio Co (SHSE:688382) Price-to-Owner-Earnings : (As of Jan. 19, 2025)


View and export this data going back to 2022. Start your Free Trial

What is InventisBio Co Price-to-Owner-Earnings?

As of today (2025-01-19), InventisBio Co's share price is ¥13.42. InventisBio Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for InventisBio Co's Price-to-Owner-Earnings or its related term are showing as below:


SHSE:688382's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 29.67
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-01-19), InventisBio Co's share price is ¥13.42. InventisBio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-0.60. Therefore, InventisBio Co's PE Ratio (TTM) for today is At Loss.

As of today (2025-01-19), InventisBio Co's share price is ¥13.42. InventisBio Co's EPS without NRI for the trailing twelve months (TTM) ended in was ¥-0.58. Therefore, InventisBio Co's PE Ratio without NRI for today is At Loss.


InventisBio Co Price-to-Owner-Earnings Historical Data

The historical data trend for InventisBio Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InventisBio Co Price-to-Owner-Earnings Chart

InventisBio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

InventisBio Co Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of InventisBio Co's Price-to-Owner-Earnings

For the Biotechnology subindustry, InventisBio Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InventisBio Co's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InventisBio Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where InventisBio Co's Price-to-Owner-Earnings falls into.



InventisBio Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

InventisBio Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=13.42/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InventisBio Co  (SHSE:688382) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


InventisBio Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of InventisBio Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


InventisBio Co Business Description

Traded in Other Exchanges
N/A
Address
No. 4, Lane 67, Li Bing Road, Room 210, Pilot Free Trade Zone, Shanghai, CHN, 201203
InventisBio Co Ltd is an innovative drug research and development enterprise based in China with a global perspective, focusing on major diseases such as tumors and metabolic diseases. It has independently developed a series of innovative targeted drugs with patent protection, covering non-small cell lung cancer, breast cancer, colorectal cancer and other solid tumors, as well as hyperuricemia and metabolic diseases such as gout.

InventisBio Co Headlines

No Headlines